← Open Payments lookup

DALE FULLER: Open Payments

NPI 1255462735 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,638 in 82 payments from 20 companies in 2025. Trend: 2023 $2,693 · 2024 $2,720 · 2025 $3,638

Food & beverage: $2,230Consulting: $1,215Travel & lodging: $193
CompanyPaymentsAmount
Madrigal Pharmaceuticals12$1,863
ABBVIE INC.24$541
Takeda Pharmaceuticals U.S.A., Inc.7$261
Ipsen Biopharmaceuticals, Inc5$228
QOL Medical, LLC4$139
Janssen Biotech, Inc.7$122
GENZYME CORPORATION2$85
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$53
Regeneron Healthcare Solutions, Inc.2$52
Aimmune Therapeutics, Inc.3$47

Products named: REZDIFFRA, IQIRVO, CREON, RINVOQ, GATTEX, SKYRIZI, Sucraid, DUPIXENT.

Industry payments across TX — which companies pay providers there.